Research progress on the mechanisms of action, pharmacological activities and clinical application of P-glycoprotein inhibitors.

Chemotherapy is an important means of cancer treatment, but multidrug resistance (MDR) is a key factor in chemotherapy failure. The mechanisms responsible for MDR are complex. The overexpression of P-glycoprotein (P-gp) is the main driving factor. P-…

Preview only. Read the full abstract at the source